Preoperative Optimization Before Bariatric Surgery in a High-Risk Patient
A 58-year-old man with a BMI of 54 kg/m² seeks bariatric surgery. He has type 2 diabetes on basal-bolus insulin with HbA1c 9.6%, obstructive sleep apnea on CPAP, stage 3b chronic kidney disease (eGFR 38 mL/min/1.73 m²), and atrial fibrillation on warfarin. He smokes one pack per day and has not seen a dietitian. He requests sleeve gastrectomy because he has heard it causes fewer vitamin problems. His cardiologist is available for coordination; the program requires a documented multidisciplinary evaluation before scheduling. He has no history of GERD, prior abdominal surgery, or bleeding. Home BP is 138/84 mm Hg; INR is 2.4. He reports 3–4 nocturnal awakenings and daytime sleepiness despite CPAP use that he estimates at 4 hours per night.
1. Identify the key modifiable risks and the targets that should be met before scheduling surgery.
Read the worked answer
Key modifiable risks: uncontrolled diabetes (HbA1c 9.6%), smoking, probable OSA undertreatment (CPAP only 4 hours/night), CKD, and lack of nutrition or behavioral preparation. Most programs require HbA1c below about 8% before surgery; 9.6% warrants insulin adjustment, diabetes education, and a delay. Smoking should stop at least 4–6 weeks before surgery to reduce pulmonary and wound complications; offer pharmacotherapy and counseling. CPAP adherence should be optimized and documented, with a repeat sleep study if symptoms persist. CKD requires baseline electrolytes, avoidance of dehydration and nephrotoxins, medication review, and nephrology input. A dietitian and behavioral evaluation are mandatory before scheduling.
2. Outline the perioperative anticoagulation and glycemic management plan.
Read the worked answer
Warfarin: coordinate with cardiology. For elective bariatric surgery, stop warfarin about 5 days before and bridge with LMWH if thromboembolic risk is high; check INR the day before surgery. Restart warfarin after hemostasis, usually 24–48 hours, with LMWH bridge until INR is therapeutic. Insulin: reduce basal insulin by about 20–30% the night before or day of surgery and hold bolus insulin while NPO; check glucose every 4–6 hours. Avoid sliding-scale-only regimens. Other: hold metformin if contrast or renal injury occurs; continue statin; use PPI and VTE prophylaxis per protocol.
3. How would you counsel him about sleeve gastrectomy versus Roux-en-Y gastric bypass, and what must happen before either operation?
Read the worked answer
Both sleeve and RYGB are defensible, but his preference should be informed. Sleeve avoids intestinal bypass and may be favored with CKD because RYGB can increase oxalate absorption and risk oxalate nephropathy; it also avoids malabsorption of iron, calcium, and B12. However, sleeve can worsen GERD, and he has no GERD now. RYGB gives stronger diabetes remission and better reflux control, but requires reliable supplementation and follow-up, and CKD increases perioperative risk.
Recommendation: do not operate until HbA1c, smoking, CPAP, and nutrition are optimized. Then use shared decision-making: if he prioritizes avoiding malabsorption and has no reflux, sleeve is reasonable; if diabetes remission is the priority and he accepts lifelong monitoring, RYGB is reasonable. Document the discussion and ensure renal and cardiology clearance.